Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Translational, interdisciplinary research projects in the field of Personalised Medicine which encourage collaboration between academia, clinical/public health research, SMEs as well as policy makers, regulatory/HTA agencies and patient organisations.
Característiques principals
With its third transnational call (non-cofunded by the EC), ERA PerMed fosters research and innovation activities that build close linkages between basic biomedical research, clinical research, physical sciences, bioengineering, bioinformatics and biostatistics, epidemiology, socio-economic research, as well as research on the integration of PM into clinical practice and on ethical, legal and social implications across the participating countries and beyond. This implies a wide range of multidisciplinary activities brought together by different stakeholders.
Research areas:
1. “Translating Basic to Clinical Research and Beyond”
  • 1A-Pre-clinical Research
  • 1B-Clinical Research
    2. “Integrating Big Data and ICT8 Solutions”
  • 2A-Data and ICT – Enabling Technology
  • 2B-Data and ICT – Towards Application in Health Care
    3. “Research towards Responsible Implementation in Health Care”
  • 3A-Optimising Health Care System
  • 3B-Ethical, Legal and Social Aspects
  • 3C-Citizen and Patient Empowerment
  • 3D-Training Strategies
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://www.erapermed.eu/joint-calls/joint-transnational-call-2020/
    Submission of proposals is mandatory on: https://ptoutline.eu/app/erapermed2020
    Informació addicional
    If you are looking for potential partners, please have a look also at the ICPerMed Partnering Tool: https://partnering.pt-dlr.de/ICPerMed
    Requisits
    Eligibility Criteria:
  • Only transnational projects shall be funded.
  • Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the call. All three legal entities must be independent from each other.
  • The project coordinator must be eligible to be funded by his/her national/regional participating funding organisations.
  • The maximum number of partners per project at the pre-proposal stage is six. At the full-proposal stage, the consortium can be increased up to seven partners in total only by inclusion of a partner coming from an underrepresented country. A list of underrepresented countries will be provided to coordinators invited for full- roposal submission.
  • Within one consortium, not more than two partners from the same country participating in the call will be accepted. For some funding agencies the maximum number of eligible partners that can be funded in one project is limited to one partner (see also "Guidelines for applicants" regarding individual funding rules).
  • Partners not eligible for funding by one of the organisations participating in this JTC (e.g. from non-funding countries or not fundable according to the national/regional regulations of the participating funding organisations) may participate in projects if they are able to secure their own funding.

    Joint research proposals may be submitted by applicants belonging to one of the following categories (according to national/regional regulations of the funding organizations, please see “Guidelines for applicants”):

    A. Academia (research teams working in universities, other higher education institutions) or research institutes;
    B. Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of medical doctors in the research teams is encouraged;
    C. (Industry) Private partners, e.g. SMEs (small and medium-size enterprises).
    Consortia submitting applications to this call are strongly encouraged to include partners from different categories (A, B and C)
    For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team members.

    Please contact the Servei de Recerca of you intend to apply for this call, in order to confirm your eligibility and the different funding entities you can apply to.
    • Dotació
    For Spanish participants:
    Between €175,000 to € €250,000 depending on the role, composition of the consortium and funding entity. Please see the Guidelines for further information.
    Durada
    3 years
    AVÍS IMPORTANT
    The submission of proposals follows a two-stage procedure:
  • Submission deadline for pre-proposals: 5 March 2020 (17:00 CET)
  • Submission deadline for full-proposals: 15 June 2020 (17:00 CEST)

    Spanish partners applying for fundong through ISCIII and FCAECC must submit in addition the form: “Additional application form for Spanish applicants applying for funding from ISCIII/FCAECC”

    • Arxius

    Arxiu
    1_ERA-PerMed_2020_Call_text_final_191216.pdf
    3_ERA-PerMed_JTC2020_Pre-Proposal_form.docx
    9_Spain_ISCIII_FCAECC_Additional-application-form-for-partners-requesting-funds-from-ISCIII-and-FCAECC_FV.docx
    Guidelines_UPDATED20Jan.pdf